A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of doxorubicin plus
sorafenib versus doxorubicin plus placebo in patients with advanced hepatocellular carcinoma
(HCC).